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bQueen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham B15 2WW, UKG R A P H I C A L A B S T R A C T
Lymphocyteswere isolated fromhuman tissue samples by enzymatic andmechanicalmethods. Treg and Tconvwere cell sorted
from the tissue cell suspension by gating the lymphocytes forward scatter–side scatter region into a CD4–Live/Dead dot plot.
CD4+ live cells were then gated into a CD127–CD25 dot plot. This last dot plot was used to deﬁne Treg (Streams 1 and 2) and
Tconv cells (Stream 3). Treg were gated into a CCR5 histogram to deﬁne CCR5low and CCR5high Treg. Thus, speciﬁc Treg subsets
were isolated for use in downstream suppression assays. Histograms depicting percentage Foxp3 expression by colorectal
cancer-isolated Treg and Tconv show representative data from 9 separate experiments. Treg isolated from colorectal cancer
therefore express high amounts of Foxp3 whereas Tconv do not.
A B S T R A C TThe suppression assay is a commonly performed assay, measuring the ability of regulatory T cells (Treg) tosuppress T cell proliferation. Most frequently, Treg are obtained from the peripheral blood or spleen. Lower yields
are obtained by isolation from other tissues, rendering downstream suppression assays challenging to perform.
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Furthermore, the importance of suppressive subpopulations of Treg favours their isolation by ﬂuorescent-
activated cell sorting. Here we describe a method to isolate Treg from human tissues, using colorectal cancer
tissue as an example. Treg suppressive capacity was further examined by expression of CCR5 to demonstrate the
ability of our method to assess the suppressive capacity of regulatory T cell subsets.
To optimise the standard suppression assay to achieve our research aims, the following modiﬁcations were
made:
 Treg, isolated from tissues, were sorted directly into a well-plate.
 Responder T cells, which had been ﬂuorescently-labelled prior to sorting, were added directly into the well-
plate.
 Human Treg Suppression Inspector beads (Miltenyi Biotec Ltd., UK) provided a polyclonal stimulus for
proliferation and were added to each well at a bead:lymphocyte ratio of 1:2.
This method quantiﬁed the suppression of responder T cell proliferation by small numbers of strictly-deﬁned
Treg populations isolated from tissues.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).
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Regulatory T cells (Treg) suppress the proliferation of conventional T cells, maintaining peripheral
tolerance. Surface markers used to deﬁne Treg are CD4, CD25 and CD127 and CD4+ CD25+ CD127low
cells express high levels of the master regulatory transcription factor, Foxp3 [1]. Most reports of
suppression assays use peripheral blood-isolated Treg, or spleen-derived Treg in the case of murine
studies, as these sources provide a high yield of lymphocytes [2–4]. Isolation of lymphocytes from
other tissues is more complex, resulting in lower yields of viable cells [5] and access may be limited to
small tissue biopsies. In our method, lymphocytes were isolated from human tissue by an enzymatic
and mechanical method. Speciﬁc lymphocyte subsets were then isolated by cell sorting and a
suppression assay was set up as detailed herein.
Samples
Peripheral blood and tissue samples of CRC were obtained from patients undergoing a bowel
resection as part of their treatment for CRC at the QEHB. Ethical approval had been obtained from the
local research and ethics committee (LREC South Birmingham 2003/242, renewed 2012) and all
patients donating tissue had given full prior consent.
Lymphocyte isolation1. CRC tissue samples were diced into small 2–3mmpieces and placed in 10ml of digestion buffer in a
C tube (130-093-237, Miltenyi Biotec Ltd., UK). This buffer contained collagenase II (20mg/ml, C2-
22, VWR International Ltd., UK) and antibiotics (penicillin 1U/ml, streptomycin 1mg/ml,
gentamicin 10mg/ml, amphotericin B 0.25mg/ml) in RPMI 1640 medium (31870-082, Life
Technologies Ltd., UK).2. The C tube was spun on the gentleMACS dissociator V1.02 (130-093-235, Miltenyi Biotec Ltd., UK)
using the h_tumour_01.01 programme and incubated for 30min at 378C with agitation. The C tube
was spun on the gentleMACS dissociator h_tumour_02.01 programme and incubated at 378C for a
further 30min with agitation. Finally, the C tube was spun on the gentleMACS dissociator
h_tumour_03.01 programme.3. Digested tissue was passed through a cell strainer (352350, BD Biosciences Ltd., UK) and layered on
top of a discontinuous gradient of 70% and 30% Percoll solutions (17-0891-01, GE Healthcare Ltd.,
UK) and centrifuged at 300g for 25min.
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1ml of RPMI 1640 media containing 1% foetal calf serum (FCS, 10270-106, Life Technologies Ltd.,
UK) and antibiotics, as above.5. 10mlperipheralblood fromhealthyvolunteerswas layeredontopofanequalvolumeofLymphoprepTM
(07851, Stemcell Technologies Ltd., UK) and centrifuged at 300g for 25min. The mononuclear cell
band was aspirated, washed and resuspended in RPMI 1640 media containing 1% FCS.
Lymphocyte labelling1. The CRC tissue cell suspension was labelled with a ﬁxable live/dead marker (L10119, Life
Technologies Ltd., UK) at 5mM concentration and incubated at 48C for 20min.2. Small volumes (50ml) of the CRC tissue cell suspensionwere used for single ﬂuorochrome labelling.
The majority of the sample (700ml) was labelled with the full antibody cocktail at 48C for 30min,
ready for cell sorting. The antibodies used to label the CRC tissue cell suspension were: anti-human
CD4-PECy7 (317414, Clone OKT4, Biolegend), anti-human CD25-APC (555434, Clone M-A251, BD),
CD127-FITC (560549, Clone HIL-7R-M21, BD) and anti-human CCR5-PE (FAB1802P, Clone CTC5,
R&D Systems). The Treg population was deﬁned as live CD4+ CD25+ CD127low cells while
conventional T cells (Tconv) were deﬁned as live CD4+ CD25 cells.3. The remaining 100ml of the samplewas used for intra-cellular staining of Foxp3 to conﬁrm the Treg
phenotype and was ﬁrst labelled with the cell surface antibodies: CD4-PECy7, CD25-APC and
CD127-FITC (as above) and then ﬁxed and permeabilised using the Foxp3/Transcription Factor
Staining Buffer Set (0-5523-00, eBioscience), according to the manufacturer’s instructions. The
permeabilised cell suspension was divided into two equal volumes: half was labelled with anti-
human Foxp3-PE (12-4776-42, eBioscience) and the other half with isotype-matched control
antibody (12-4321-42, eBioscience) at 48C for 30min. These samples were analysed by ﬂow
cytometry following colour compensation using single ﬂuorochrome-labelled samples, allowing
assessment of Foxp3 expression of CD4+ CD25+ CD127low cells (see Graphical Abstract).4. Peripheral blood isolated mononuclear cells were labelled with CellTrace Violet dye (C34557, Life
Technologies Ltd., UK) at 37 8C for 20min and washed twice. The cell suspension was labelled with
CD4-PECy7 and CD25-APC antibodies, as above. CellTrace Violet-labelled CD4+CD25 cells are
referred to as responder T cells (Tresp).
Cell sorting1. Cell sortingwas used to add Treg or Tconv to a 96-well plate followed by Tresp. The Treg population
was deﬁned by gating on live CD4+ CD25+ CD127low cells while Tconvwere deﬁned by gating on live
CD4+ CD25 cells (see Graphical Abstract).2. Each well of a round-bottomed 96-well plate was ﬁlled with 100ml of RPMI+10% FCS. An equal
number of CCR5low Treg, CCR5high Treg and Tconvwere 3-way sorted from labelled CRC-isolated cell
suspension into separate wells using a MoFlo XDP High-Speed Cell Sorter (Beckman Coulter Inc.,
USA) in purity mode. In some cases, sorted lymphocytes were analysed on a ﬂow cytometer to
assess purity (see Fig. 1). Typical yields were between 10000 and 60000 Treg, according to the
sorter event counter. In cases with high yields, 10000 CCR5low Treg, CCR5high Treg and Tconv were
3-way sorted into separate Eppendorfs containing 1ml of PBS in preparation for later DNA
extraction and analysis of the TSDR (Treg-speciﬁc demethylated region).3. Violet-labelled Tresp (peripheral blood-isolated CD4+CD25 cells) were plate-sorted into the same
wells as the previously sorted Treg and Tconv, yielding Treg/Tconv:Tresp ratios of 1:1, 1:2 or 1:4.
Suppression assay
Human Treg Suppression Inspector beads (Miltenyi Biotec Ltd., UK) provided a polyclonal stimulus
for proliferation and were added to each well at a bead:lymphocyte ratio of 1:2. The total volume of
each well was made up to 200ml with RPMI 1640 media+10% FCS. The plate was incubated at 37 8C
[(Fig._1)TD$FIG]
Fig. 1. Purity check of sorted Treg and Tconv from two samples. Percentages in top-right of histogram represent the purity of
sorted Treg subsets.
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Beckman Coulter). Violet-labelled cells cultured alone, in the absence of bead stimulation, were used
as a negative control, enabling a gate to be set around the proliferating cell population. The percentage
of Tresp proliferating is thus easily determined. However a small number of proliferating Tresp
undergoing multiple divisions will have the effect of under-representing the suppressive capacity of
Treg, an effect that can be overcome by measuring the division index (DI). The DI is deﬁned as the
average number of divisions for all Tresp in the culture and was calculated using Flowjo version 8.7
(Tree Star Inc.) [6]. Results were reported as percent suppression [3]:
Percent suppression ¼ 100 Percentage of proliferating cells ðorDIÞwithTregpresent
Percentage of proliferating cells ðorDIÞwithout Treg present100
Differences in percent suppression, calculated using both percentage of proliferating cells and DI,
between CRC-isolated Treg and CD4+CD25 cells were tested for statistical signiﬁcance using the
Wilcoxin signed-rank test.
Representative results from one experiment, in which enough Treg were isolated to perform three
different Treg:Tresp ratios, are shown in Fig. 2. Following 72h of culture, 75% of Tresp proliferated in
response to Treg Suppression Inspector beads alone. Both CRC-isolated CCR5low Treg and CCR5high Treg
suppressed proliferation of Tresp in a dose-dependent manner, while CRC-isolated Tconv did not. The
differences in percent suppression by CCR5low Treg, CCR5high Treg and Tconv were compared using
pooled data for Treg:Tresp ratios of 1:1 and 1:2 over a series of ﬁve experiments (see Table 1). Both
CCR5low Treg and CCR5high Treg suppressed Tresp proliferation signiﬁcantly more then Tconv,
P=0.043 and P=0.018, respectively. Also, CCR5high Treg suppressed Tresp proliferation signiﬁcantly
more than CCR5low Treg (P=0.018), an effect that has been noted previously in patients with psoriasis
[7].
TSDR analysis
TSDR analysis was performed on sorted Treg to show that Treg isolated from human tissues were
naturally-occurring Treg as opposed to induced Treg.1. Eppendorfs containing sorted Treg and Tconv were pelleted by centrifugation in a microfuge at
300g for 10min then resuspended in 200ml of PBS. DNA was extracted from the cell suspensions
using the DNeasy Blood & Tissue Kit (69504, Qiagen) according to the manufacturer’s instructions.
DNA samples were bisulphite treated using the Epitect Bisulﬁte kit (59104, Qiagen) and the
quantity and quality of recovered bisulphite-treated DNA was assessed by measurement of UV
absorbance at 260/280nm.2. The TSDR region was ampliﬁed using primers designed to amplify the TSDR region irrespective of
its methylation status. A Taqman1 probe labelled with 6-carboxyﬂuorescein (FAM) was designed
to speciﬁcally bind to an unmethylated sequence while another Taqman1 probe labelled
[(Fig._2)TD$FIG]
Fig. 2. Suppression assay using CCR5low and CCR5high Treg isolated from one sample of CRC. (A) Tresp proliferation following
72h of culture with or without Treg Suppression Inspector beads. (B) Tresp proliferation following 72h of culture with Treg
Suppression Inspector beads and either CRC-isolated CCR5low Treg, CCR5high Treg or Tconv. Numbers at the top-right of each
histogram indicates the percentage of proliferating cells.
Table 1
Suppression assay summary.
Experiment Ratio
Treg:
Tresp
Number
Treg/
Tconv
Percent suppression using the percentage
of proliferating cells (%)
Percent suppression using the Divison
Index (%)
CCR5low
Treg
CCR5high
Treg
Tconv CCR5low
Treg
CCR5high
Treg
Tconv
A 1:1 10000 28.5 32.1 0.0 82.0 87.4 37.1
B 1:1 5000 75.1 81.4 16.0 96.1 95.9 44.9
C 1:1 10000 58.8 83.6 16.7 75.2 88.1 46.6
D 1:1 10000 6.7 46.6 1.3 28.8 61.3 2.7
C 1:2 5000 45.3 77.7 11.6 85.1 91.8 39.1
D 1:2 5000 8.7 34.3 16.8 37.8 74.8 34.2
E 1:2 5000 55.1 72.2 0.7 85.8 92.8 4.1
C 1:4 2500 29.7 60.9 2.7 61.5 85.1 16.8
D 1:4 2500 0.0 6.0 9.4 3.6 28.8 0.9
Pooled data for ratios 1:1 and 1:2 45.3 72.2 0.7 82.0 88.1 37.1
Median (interquartile range) (18.6–56.9) (40.4–79.6) (2.1 to 14.1) (56.5–85.5) (81.1–92.3) (69.2–42.0)
Percent suppression method CCR5low Treg
versus Tconv
CCR5high Treg
versus Tconv
CCR5low Treg versus
CCR5high Treg
Percentage of proliferating cells 0.043 0.018 0.018
Division index 0.018 0.018 0.028
The percent suppression of Tresp proliferation is shown for CRC-isolated CCR5low Treg, CCR5high Treg and Tconv at different
Treg:Tresp ratios. The number of Treg/Tconv represents the number of sort events given by the MoFlo XDP High-Speed Cell
Sorter, rather than the absolute number of sorted viable cells.
The differences in percent suppression for ratios of 1:1 and 1:2 between different cell populations were tested for statistical
signiﬁcance using the Wilcoxon signed-rank test (P-values shown below).
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Fig. 3. Percentage of unmethylated DNA at the TSDR by cell type. The mean percentage of unmethylated DNA is plotted for
Tconv, CCR5low Treg and CCR5high Treg, isolated from four different colorectal cancer samples. Error bars represent the range
of percentage of unmethylated DNA. Capped lines represent a statistically signiﬁcant difference (Wilcoxon signed-rank test).
Sorted Treg are naturally-occurring thymic emigrants.
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methylated sequence. To achieve maximum speciﬁcity, each probe was designed to span 3 CpGs
within the TSDR. The primers, probes and method have been previously published [8]. Primers and
probes were obtained from Applied Biosystems Inc., USA.3. The following programme was run using the LightCycler 480:Pre-incubation 1 cycle – 95 8C for 10min
Ampliﬁcation 55 cycles – 958C for 15s; 60 8C for 60s
Colour compensation 1 cycle – 95 8C for 10s; 40 8C for 30s
85 8C, continuous acquisition mode, 5 acquisitions per 1 8C
Cooling 1 cycle – 40 8C for 10s4. VIC and FAM were colour-compensated using the LightCycler 480 software followed by
absolute quantiﬁcation of unmethylated and methylated target expression. The average
methylated Ct was subtracted from the average unmethylated Ct to yield a @Ct value. The
percentage of unmethylatedDNAwas estimated by plotting the@Ct value on a published standard
curve [8].5. Analysis of the demethylation status at the TSDR for CCR5low Treg, CCR5high Treg and Tconv, isolated
from four different CRC samples, revealed a signiﬁcantly greater percentage of unmethylated DNA
at the TSDR for both CCR5low- and CCR5high Treg compared with Tconv (see Fig. 3).
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